Nacuity Pharmaceuticals

United States
Fort Worth, Texas, United States, 76102

Company profile

Nacuity Pharmaceuticals company profile

Nacuity Pharmaceuticals is a pharmaceutical company that aims to develop a breakthrough treatment for retinitis pigmentosa (“RP”) and potentially other ophthalmological indications. Nacuity has assembled an accomplished team and has received significant financial and technical support from the Foundation Fighting Blindness (FFB). FFB aims to drive research providing prevention, treatments and cures for people affected by blinding retinal diseases. FFB has invested nearly $700 million in this effort Over the last 46 years. FFB is a significant supporter of Dr. Campochiaro’s research and has committed to fund a substantial portion of Nacuity’s Phase 1 and Phase 2 trials through a milestone-based matching program grant to Nacuity in support of our NPI-001 development program.

Business identity

Phone number
817-336-3000
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2016-01-01, Year

Headquarters

Postal code
76102
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$18.5M
Last funding
Series B / $16.5M / 2022-06-15
Last equity funding
Series B / $16.5M
Investors
4
Lead investors
1
Founders
4
Articles
31

Founders and investors

Founders

David WohlbergHalden ConnerIsaac BlechSanford Hillsberg

Lead investors

Foundation Fighting Blindness

Investors

Foundation Fighting BlindnessHugo PerisMaxim GroupRetinal Degeneration Fund